Home Site Map Contact Us Social Media MSF Offices xml  

Intellectual Property

Press Coverage | May 9, 2013

Philadelphia Inquirer: Merck, GlaxoSmithKline Join GAVI in Pricing Agreement for HPV Vaccine in Developing Countries

While drug companies celebrate price reductions that will allow girls in poor countries to be vaccinated against cervical cancer for $14 per patient, these prices are still out of reach for millions of people, MSF's Kate Elder explains.

Press Coverage | May 9, 2013

NYT: Prices Cut for Cervical Cancer Vaccines for Neediest

New vaccines, including for cervical cancer, are still priced too high to reach many girls in the world's poorest countries, according to MSF's Kate Elder.

Press Coverage | January 4, 2013

AP: Indian Court To Rule On Generic Drug Industry

 

India's Supreme Court is expected to rule on a case with major implications for the global supply of generic medications. MSF's Leena Menghaney and Petros Isaakidis warn about the potential consequences for patients.

Briefing Documents | February 16, 2012

Submission to the US Trade Representative Regarding the 2012 Special 301 Review Process

Read MSF's submission to the US trade representative on the 2012 Special 301 review process, which affects accessibility of medicines and important diagnostic tools.